Cargando…

The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development

Recent epidemiological studies show that postmenopausal women taking estrogen-progestin hormone replacement therapy (HRT) have a higher risk of breast cancer than women on an HRT regimen lacking progestins. This may be related to the observation that progestin-treated breast cancer cells express and...

Descripción completa

Detalles Bibliográficos
Autores principales:	CARROLL, CANDACE E., LIANG, YAYUN, BENAKANAKERE, INDIRA, BESCH-WILLIFORD, CYNTHIA, HYDER, SALMAN M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583650/ https://www.ncbi.nlm.nih.gov/pubmed/23123638 http://dx.doi.org/10.3892/ijo.2012.1675

Ejemplares similares

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts
por: Cook, Matthew T., et al.
Publicado: (2015)

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook, Matthew T, et al.
Publicado: (2016)

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
por: Liang, Yayun, et al.
Publicado: (2018)

SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine
por: Liang, Yayun, et al.
Publicado: (2019)

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang, Yayun, et al.
Publicado: (2019)

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
por: Goyette, Sandy, et al.
Publicado: (2017)

Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells
por: Liang, Yayun, et al.
Publicado: (2017)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
por: Shamseddin, Marie, et al.
Publicado: (2021)

Progestins as Anticancer Drugs and Chemosensitizers, New Targets and Applications
por: Fedotcheva, Tatiana A., et al.
Publicado: (2021)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
por: Ward, Ashley V., et al.
Publicado: (2022)

Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study
por: de Oliveira, Renato, et al.
Publicado: (2021)

Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling
por: Mohammed, Ghada, et al.
Publicado: (2021)

MtNF-YC6 and MtNF-YC11 are involved in regulating the transcriptional program of arbuscular mycorrhizal symbiosis
por: Deng, Chen, et al.
Publicado: (2022)

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
por: Sato, Takahiro, et al.
Publicado: (2013)

Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Biodegradation of Uric Acid by Bacillus paramycoides-YC02
por: Cao, Xiaoyu, et al.
Publicado: (2023)

Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007)

Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis
por: Asi, Noor, et al.
Publicado: (2016)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer
por: Pateetin, Prangwan, et al.
Publicado: (2021)

Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)
por: Dijkman, Benthe A M, et al.
Publicado: (2023)

Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
por: Yang, Ai-Min, et al.
Publicado: (2022)

Editorial: Recent advances in progestin-primed ovarian stimulation
por: Chen, Qiuju
Publicado: (2022)

Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies
por: Schairer, Catherine
Publicado: (2002)

Progestins and mammary cancer induction.
por: Coezy, E., et al.
Publicado: (1973)

Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
por: Parveen, Amna, et al.
Publicado: (2019)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations
por: Zaurin, Roser, et al.
Publicado: (2021)

Effects of YC-1 on Learning and Memory Functions of Aged Rats
por: Celikyurt, Ipek Komsuoglu, et al.
Publicado: (2014)

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
por: Santini, Daniele, et al.
Publicado: (2015)

Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells
por: Bache, Matthias, et al.
Publicado: (2015)

Lysimachia christinae Hance as an anticancer agent against breast cancer cells
por: Kim, Hyun A., et al.
Publicado: (2020)

Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
por: Al-Jumaili, Mohammed Hadi Ali, et al.
Publicado: (2021)

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study
por: Crandall, Carolyn, et al.
Publicado: (2005)

Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells
por: Pang, Haiyan, et al.
Publicado: (2004)

The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
por: Aupperlee, Mark D., et al.
Publicado: (2018)

Author Correction: Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer
por: Pateetin, Prangwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sj6s6sc41h4kvhc5nane2hfkha